Literature DB >> 2029549

Analysis of the monocyte chemotactic response to lysophosphatidylcholine: role of lysophospholipase C.

M T Quinn1, N Kondratenko, S Parthasarathy.   

Abstract

Previously, we reported that lysophosphatidylcholine (lyso-PtdCho), a component of oxidized low-density lipoprotein, was a monocyte chemoattractant (M.T. Quinn et al. (1988) Proc. Natl. Acad. Sci. USA 85, 2805-2809). Monocyte chemotaxis was also stimulated by lyso-platelet activating factor but not by platelet activating factor itself. In the present studies, we used other analogs of lyso-PtdCho to determine structural and metabolic features required for chemotactic activity. Although both D- and L-lyso-PtdCho stimulated chemotaxis, suggesting a lack of stereospecificity, studies using propanediol and ethanediol analogs of lyso-PtdCho suggested that a free hydroxyl moiety or an ester-linked fatty acid vicinal to the phosphocholine group of the lysophospholipid was required for the expression of activity. Incubation of [3H]choline-labeled lyso-PtdCho with monocytes resulted in the formation of labeled PtdCho, glycerophosphocholine (GPC), phosphocholine, and free choline, while resident peritoneal macrophages, cells which we show do not respond chemotactically to lyso-PtdCho, metabolized the labeled substrate to generate only labeled PtdCho and GPC; no labeled phosphocholine was found, suggesting a possible role for lysophospholipase C activity in the monocyte chemotactic response. Although monoacylglycerol, the product of lysophospholipase C hydrolysis of lyso-PtdCho, was not chemotactic for monocytes, diacylglycerol demonstrated chemotactic activity, suggesting that the subsequent acylation to diacylglycerol may be involved in the monocyte chemotactic response to lyso-PtdCho. Indeed, monocytes incorporated [3H]glycerol from [3H]glycerol-labeled lyso-PtdCho into di- and triacylglycerol. Based on these results, a model is proposed whereby the monocyte chemotactic response to lyso-PtdCho involves a sequence of metabolic steps which includes hydrolysis of lyso-PtdCho to monoacylglycerol and phosphocholine by lysophospholipase C followed by acylation of monoacylglycerol to diacylglycerol. Diacylglycerol would then act as an intracellular second messenger that could activate or facilitate the chemotactic response.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2029549     DOI: 10.1016/0005-2760(91)90205-v

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor.

Authors:  C H MacPhee; K E Moores; H F Boyd; D Dhanak; R J Ife; C A Leach; D S Leake; K J Milliner; R A Patterson; K E Suckling; D G Tew; D M Hickey
Journal:  Biochem J       Date:  1999-03-01       Impact factor: 3.857

2.  Lysophosphatidylcholine upregulates the level of heparin-binding epidermal growth factor-like growth factor mRNA in human monocytes.

Authors:  T Nakano; E W Raines; J A Abraham; M Klagsbrun; R Ross
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

3.  Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells.

Authors:  N Kume; M I Cybulsky; M A Gimbrone
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

4.  Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes.

Authors:  H F McMurray; S Parthasarathy; D Steinberg
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

5.  In vitro effects of oxidized low density lipoprotein on CD11b/CD18 and L-selectin presentation on neutrophils and monocytes with relevance for the in vivo situation.

Authors:  H A Lehr; F Krombach; S Münzing; R Bodlaj; S I Glaubitt; D Seiffge; C Hübner; U H von Andrian; K Messmer
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

6.  Lysophosphatidylcholine: a chemoattractant to human T lymphocytes.

Authors:  A K Ryborg; B Deleuran; K Thestrup-Pedersen; K Kragballe
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

7.  Saturated and mono-unsaturated lysophosphatidylcholine metabolism in tumour cells: a potential therapeutic target for preventing metastases.

Authors:  Anna Raynor; Peter Jantscheff; Thomas Ross; Martin Schlesinger; Maurice Wilde; Sina Haasis; Tim Dreckmann; Gerd Bendas; Ulrich Massing
Journal:  Lipids Health Dis       Date:  2015-07-11       Impact factor: 3.876

8.  Elevated Serum Lysophosphatidylcholine in Patients with Systemic Lupus Erythematosus Impairs Phagocytosis of Necrotic Cells In Vitro.

Authors:  Gerhard E Grossmayer; Hildegard Keppeler; Sebastian Boeltz; Christina Janko; Jürgen Rech; Martin Herrmann; Kirsten Lauber; Luis E Muñoz
Journal:  Front Immunol       Date:  2018-01-17       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.